Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AB Multi-Manager Alternative FundNONE · Entity 1485 | Director of Fund's Adviser | January 01, 2020 | January 13, 2020 |
| ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND INCAWF · Entity 5051 | Director of Fund's Adviser | January 01, 2020 | January 13, 2020 |
| ALLIANCEBERNSTEIN HOLDING L.P.AB · Entity 4151 | Director | May 24, 2023 | May 26, 2023 |
| ALLIANCEBERNSTEIN L.P.NONE · Entity 66568 | Director | January 01, 2020 | January 13, 2020 |
| ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUNDAFB · Entity 8874 | Director of Fund's Adviser | January 01, 2020 | January 13, 2020 |
| COGNIZANT TECHNOLOGY SOLUTIONS CORPCTSH · Entity 473 | Director | November 30, 2023 | December 04, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AB Multi-Manager Alternative Fund
Report date January 01, 2020 · Filed January 13, 2020
This filing explicitly reported no securities owned.
ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND INC
Report date January 01, 2020 · Filed January 13, 2020
This filing explicitly reported no securities owned.
ALLIANCEBERNSTEIN HOLDING L.P.
Report date May 24, 2023 · Filed May 26, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| AB Holding UnitsSEC Table I · non-derivative | Direct | 22,865 |
Reported balance
After 2023-05-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-05-24 · Grant · Acquired 5,017 · Balance 22,865 F1: Units representing assignments of beneficial ownership of limited partnership interests in AllianceBernstein Holding L.P. ("AB Holding Units") F2: The Board of Directors of AllianceBernstein Corporation, general partner of AB Holding, granted 5,017 restricted AB Holding Units to the Reporting Person during a meeting of the Board held on May 24, 2023; each Independent Director recused himself or herself from approving this grant. The AB Holding Units will vest and be delivered in equal 33.3% increments on each of May 24, 2024, 2025 and 2026. F3: Closing price of an AB Holding Unit (NYSE: AB) on the grant date (May 24, 2023). |
Filing footnotes · ownership attribution and instrument terms
F1: Units representing assignments of beneficial ownership of limited partnership interests in AllianceBernstein Holding L.P. ("AB Holding Units")
F2: The Board of Directors of AllianceBernstein Corporation, general partner of AB Holding, granted 5,017 restricted AB Holding Units to the Reporting Person during a meeting of the Board held on May 24, 2023; each Independent Director recused himself or herself from approving this grant. The AB Holding Units will vest and be delivered in equal 33.3% increments on each of May 24, 2024, 2025 and 2026.
F3: Closing price of an AB Holding Unit (NYSE: AB) on the grant date (May 24, 2023).
ALLIANCEBERNSTEIN L.P.
Report date January 01, 2020 · Filed January 13, 2020
This filing explicitly reported no securities owned.
ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND
Report date January 01, 2020 · Filed January 13, 2020
This filing explicitly reported no securities owned.
COGNIZANT TECHNOLOGY SOLUTIONS CORP
Report date November 30, 2023 · Filed December 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 955.9227 |
Reported balance
After 2023-11-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-11-30 · Grant · Acquired 3.9227 · Balance 955.9227 F1: The Board of Directors (the "Board") of Cognizant Technology Solutions Corporation (the "Company") has determined that all dividend equivalent rights on outstanding and any future restricted stock units (including deferred stock units and restricted stock units with deferred and non-deferred settlement) granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms (including vesting and settlement) as the restricted stock units to which they relate. F2: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F3: The restricted stock units will vest fully on February 21, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,552.5783 |
Reported balance
After 2023-11-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-11-30 · Grant · Acquired 14.5783 · Balance 3,552.5783 F1: The Board of Directors (the "Board") of Cognizant Technology Solutions Corporation (the "Company") has determined that all dividend equivalent rights on outstanding and any future restricted stock units (including deferred stock units and restricted stock units with deferred and non-deferred settlement) granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms (including vesting and settlement) as the restricted stock units to which they relate. F2: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4: The restricted stock units will vest fully on June 6, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The Board of Directors (the "Board") of Cognizant Technology Solutions Corporation (the "Company") has determined that all dividend equivalent rights on outstanding and any future restricted stock units (including deferred stock units and restricted stock units with deferred and non-deferred settlement) granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms (including vesting and settlement) as the restricted stock units to which they relate.
F2: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company.
F3: The restricted stock units will vest fully on February 21, 2024.
F4: The restricted stock units will vest fully on June 6, 2024.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Change Healthcare Inc.
Report date October 03, 2022 · Filed October 05, 2022
Section 16 reporting ended · disclosed 2022-10-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 1
1 source rowRow 1 · 2022-10-03 · Disposition to issuer · Disposed 29,280 · Balance 0 F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax. F2: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax.
F2: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2023 Filed Dec 4, 2023 21:37 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 14.5783 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-23-000382 · wk-form4_1701725860.xml · derivative · entry 2 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,552.5783 Underlying: Class A Common Stock · 14.5783 shares Expires not disclosed F1 · security: The Board of Directors (the "Board") of Cognizant Technology Solutions Corporation (the "Company") has determined that all dividend equivalent rights on outstanding and any future restricted stock units (including deferred stock units and restricted stock units with deferred and non-deferred settlement) granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms (including vesting and settlement) as the restricted stock units to which they relate. F2 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F2 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · derivative.exercise_date: The restricted stock units will vest fully on June 6, 2024. F4 · derivative.expiration_date: The restricted stock units will vest fully on June 6, 2024. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:37 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 3.9227 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-23-000382 · wk-form4_1701725860.xml · derivative · entry 1 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 955.9227 Underlying: Class A Common Stock · 3.9227 shares Expires not disclosed F1 · security: The Board of Directors (the "Board") of Cognizant Technology Solutions Corporation (the "Company") has determined that all dividend equivalent rights on outstanding and any future restricted stock units (including deferred stock units and restricted stock units with deferred and non-deferred settlement) granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms (including vesting and settlement) as the restricted stock units to which they relate. F2 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F2 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units will vest fully on February 21, 2024. F3 · derivative.expiration_date: The restricted stock units will vest fully on February 21, 2024. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:32 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 3,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-23-000203 · wf-form4_168625632288125.xml · derivative · entry 1 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,538 Underlying: Class A Common Stock · 3,538 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of Cognizant Technology Solutions Corporation. F2 · derivative.exercise_date: The RSUs will vest fully on June 6, 2024. F2 · derivative.expiration_date: The RSUs will vest fully on June 6, 2024. Read SEC document |
| May 24, 2023 Filed May 26, 2023 18:07 UTC | ALLIANCEBERNSTEIN HOLDING L.P. AB · Entity 4151 | GrantAB Holding Units | 5,017 | $33.89 | $170,026.13 |
DisclosureSEC source: 0001798944-23-000002 · wf-form4_168512443170659.xml · nonDerivative · entry 1 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,865 F1 · security: Units representing assignments of beneficial ownership of limited partnership interests in AllianceBernstein Holding L.P. ("AB Holding Units") F2 · kind: The Board of Directors of AllianceBernstein Corporation, general partner of AB Holding, granted 5,017 restricted AB Holding Units to the Reporting Person during a meeting of the Board held on May 24, 2023; each Independent Director recused himself or herself from approving this grant. The AB Holding Units will vest and be delivered in equal 33.3% increments on each of May 24, 2024, 2025 and 2026. F2 · shares: The Board of Directors of AllianceBernstein Corporation, general partner of AB Holding, granted 5,017 restricted AB Holding Units to the Reporting Person during a meeting of the Board held on May 24, 2023; each Independent Director recused himself or herself from approving this grant. The AB Holding Units will vest and be delivered in equal 33.3% increments on each of May 24, 2024, 2025 and 2026. F3 · price: Closing price of an AB Holding Unit (NYSE: AB) on the grant date (May 24, 2023). Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:55 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 952 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-23-000068 · wf-form4_167718929080423.xml · derivative · entry 1 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952 Underlying: Class A Common Stock · 952 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of Cognizant Technology Solutions Corporation. F2 · derivative.exercise_date: The RSUs will vest fully on February 21, 2024. F2 · derivative.expiration_date: The RSUs will vest fully on February 21, 2024. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:32 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerCommon Stock | 29,280 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-033014 · doc4.xml · nonDerivative · entry 1 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax. F2 · shares: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. F1 · price: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax. F2 · price: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:48 UTC | ALLIANCEBERNSTEIN HOLDING L.P. AB · Entity 4151 | GrantAB Holding Units | 4,410 | $38.55 | $170,005.50 |
DisclosureSEC source: 0001798944-22-000002 · wf-form4_165333888439165.xml · nonDerivative · entry 1 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,848 F1 · security: Units representing assignments of beneficial ownership of limited partnership interests in AllianceBernstein Holding L.P. ("AB Holding Units") F2 · kind: The Board of Directors of AllianceBernstein Corporation, general partner of AB Holding, granted 4,410 restricted AB Holding Units to the Reporting Person during a meeting of the Board held on May 19, 2022; each Independent Director recused himself or herself from approving this grant. The AB Holding Units will vest and be delivered in equal increments on each of May 19, 2023, 2024 and 2025. F2 · shares: The Board of Directors of AllianceBernstein Corporation, general partner of AB Holding, granted 4,410 restricted AB Holding Units to the Reporting Person during a meeting of the Board held on May 19, 2022; each Independent Director recused himself or herself from approving this grant. The AB Holding Units will vest and be delivered in equal increments on each of May 19, 2023, 2024 and 2025. F3 · price: Closing price of an AB Holding Unit (NYSE: AB) on the grant date (May 19, 2022). Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 17:07 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 7,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-010882 · form4.xml · nonDerivative · entry 1 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,280 F1 · shares: Represents the grant of deferred stock units that vest on April 25, 2023. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 14:27 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 7,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-005919 · form4.xml · nonDerivative · entry 1 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,622 F1 · shares: Represents the grant of deferred stock units that vests on June 22, 2022. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:07 UTC | ALLIANCEBERNSTEIN HOLDING L.P. AB · Entity 4151 | GrantAB Holding Units | 3,918 | $43.30 | $169,649.40 |
DisclosureSEC source: 0001798944-21-000002 · wf-form4_162188682089447.xml · nonDerivative · entry 1 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,438 F1 · security: Units representing assignments of beneficial ownership of limited partnership interests in AllianceBernstein Holding L.P. ("AB Holding Units") F2 · price: Closing price of an AB Holding Unit (NYSE: AB) on the grant date (May 20, 2021). Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 16:38 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 14,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-20-002925 · form4.xml · nonDerivative · entry 1 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,486 F1 · shares: Represents the grant of deferred stock units that vests on June 17, 2021. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:06 UTC | ALLIANCEBERNSTEIN HOLDING L.P. AB · Entity 4151 | GrantAB Holding Units | 7,176 | $23.69 | $169,999.44 |
DisclosureSEC source: 0001798944-20-000015 · wf-form4_159017799604136.xml · nonDerivative · entry 1 Domenici Nella · CIK 0001798944 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,520 F1 · security: Units representing assignments of beneficial ownership of limited partnership interests in AllianceBernstein Holding L.P. ("AB Holding Units") F2 · kind: The Board of Directors of AllianceBernstein Corporation, general partner of AB Holding, granted 7,176 restricted AB Holding Units to the Reporting Person during a meeting of the Board held on May 20, 2020; each Independent Director recused himself or herself from approving this grant. The AB Holding Units will vest and be delivered in equal 25% increments on each of May 20, 2021, 2022, 2023 and 2024. F3 · price: The closing price on the NYSE of an AB Holding Unit on May 20, 2020, the award date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.